Ocumetics Technology Corp. (OTCFF)
USD 0.19
(0.0%)
USD 0.19
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.48 Million CAD | 65.85% |
| 2022 | 2.1 Million CAD | 251.62% |
| 2021 | 598.19 Thousand CAD | 246.81% |
| 2020 | 172.48 Thousand CAD | 382.72% |
| 2019 | 35.73 Thousand CAD | -52.96% |
| 2018 | 75.95 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 583.73 Thousand CAD | -14.06% |
| 2023 Q3 | 737.44 Thousand CAD | -50.46% |
| 2023 FY | 3.48 Million CAD | 65.85% |
| 2023 Q4 | 679.26 Thousand CAD | -7.89% |
| 2023 Q2 | 1.48 Million CAD | 123.74% |
| 2023 Q1 | 665.34 Thousand CAD | 30.85% |
| 2022 FY | 2.1 Million CAD | 251.62% |
| 2022 Q2 | 644.44 Thousand CAD | 24.93% |
| 2022 Q4 | 508.46 Thousand CAD | 0.58% |
| 2022 Q1 | 515.82 Thousand CAD | 11.39% |
| 2022 Q3 | 505.55 Thousand CAD | -21.55% |
| 2021 Q1 | 42.34 Thousand CAD | 238.24% |
| 2021 Q4 | 463.06 Thousand CAD | 0.0% |
| 2021 Q2 | 9646.00 CAD | -77.22% |
| 2021 FY | 598.19 Thousand CAD | 246.81% |
| 2020 Q1 | 24.64 Thousand CAD | 0.0% |
| 2020 Q3 | 102.46 Thousand CAD | -10.18% |
| 2020 Q2 | 114.07 Thousand CAD | 362.88% |
| 2020 Q4 | 12.52 Thousand CAD | -87.78% |
| 2020 FY | 172.48 Thousand CAD | 382.72% |
| 2019 FY | 35.73 Thousand CAD | -52.96% |
| 2018 FY | 75.95 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -21.829% |
| Ansell Limited | 495.5 Million USD | 99.296% |
| Ansell Limited | 495.5 Million USD | 99.296% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 95.787% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -101.551% |
| Psykey, Inc. | 1.21 Million USD | -187.467% |
| ConvaTec Group Plc | 910.31 Million USD | 99.617% |
| ConvaTec Group Plc | 872.5 Million USD | 99.6% |
| Encision Inc. | 3.77 Million USD | 7.636% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -2359.862% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -3073.222% |
| Innovative MedTech Inc. | 6.09 Million USD | 42.804% |
| LifePoint, Inc. | 7.42 Million USD | 53.012% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 45.057% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -307.995% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -380.401% |
| Reflect Scientific, Inc. | 1.06 Million USD | -227.946% |
| SmileDirectClub, Inc. | 517 Million USD | 99.325% |
| Sector 10, Inc. | 39.84 Thousand USD | -8655.032% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.947% |
| SheerVision, Inc. | 2.33 Million USD | -49.61% |
| United Health Products, Inc. | 2.42 Million USD | -43.758% |
| Vasamed, Inc. | 4.67 Million USD | 25.349% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -36.168% |
| Yubo International Biotech Limited | 1.25 Million USD | -177.321% |